Skip to content

ATHR ATHR Prepaid Development Costs

Prepaid Development Costs at other companies

Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$4.89M+159%
Ocean Power Technologies logo
Ocean Power TechnologiesOPTT
$478K+1,266%
Immix Biopharma, Inc. logo
Immix Biopharma, Inc.IMMX
$1.23M+229%
Esperion Therapeutics logo
Esperion TherapeuticsESPR
$5.79M+1,049%
Relmada Therapeutics, Inc. logo
Relmada Therapeutics, Inc.RLMD
$866.6K+226%
Lightwave Logic, Inc. logo
Lightwave Logic, Inc.LWLG
$232.67K-4.9%

Other financials

Income statement

See full
Revenue$336.0K-1.7%
Gross profit$271.3K+16.8%
Net income-$1.0M-164%
EPS (diluted)-$0.08-100%

Balance sheet

See full
Cash & equivalents$808.0K+318%
Total equity$2.3M+493%
Total assets$3.0M+711%

Cash flow

See full
Operating cash flow-$919.2K-786%
CapEx$1.2M
Free cash flow-$919.2K

Valuation

See full
Market cap$57.2M-65.4%
P/S42.1×-76.8×

Profitability

See full
Gross margin76.6%+7.9pp
Net margin-349.9%-572pp

Returns & leverage

See full
Return on equity-135.6%
Current ratio1.7×+1.3×

Where this comes from

Reported directly by ATHR in its filing.

Tagged under the XBRL concept ATHR:PrepaidDevelopmentCosts.

The official record: ATHR’s 10-K, filed December 17, 2025, on SEC EDGAR. View the filing →

Ask your AI about ATHR's prepaid development costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ATHR's prepaid development costs?
ATHR (ATHR) reported prepaid development costs of $100K in Q3 2025.
What does prepaid development costs mean?
This represents payments made in advance to third-party vendors or contractors for the development of proprietary technology, software, or platform features that have not yet been fully realized. It reflects the company's investment in future product capabilities and R&D initiatives. Monitoring this helps investors assess the pipeline of upcoming platform enhancements.